Maximize Your Visibility
Product Theaters are turnkey, 45-minute marketing presentations about your company’s products or services. These sessions do not offer CME credit; rather, they give industry supporters the freedom to create a presentation centered on their company’s products.
Only DDW industry supporters who have secured a booth are eligible to apply for a slot for a product theater, subject to availability and adherence to all published guidelines.
Book your theater
We are accepting applications until March 7, 2025. Slots are assigned based on receipt of full payment. Please view the rules and regulations for additional details.
Schedule
DDW Theaters are located in the Exhibit Hall. Below is the current schedule (times are listed in PDT).
| 9 a.m. | Discover VELSIPITY® (etrasimod): An Rx tablet treatment option from Pfizer |
| Supported by: Pfizer | |
| 9:45–10:30 a.m. | |
| DDW Theater 1 | |
| 10 a.m. | Pursuing Control in Crohn’s |
| Supported by: AbbVie | |
| 10:20–11:05 a.m. | |
| DDW Theater 2 | |
| 11 a.m. | Empowering Care for Adult Patients with IBS-C |
| Supported by: AbbVie | |
| 11–11:45 a.m. | |
| DDW Theater 1 | |
| Strive Towards Treatment Goals | |
| Supported by: Lilly USA | |
| 11:35 a.m.–12:20 p.m. | |
| DDW Theater 2 | |
| Noon | Expert Insights on GERD Therapy: A Case-Based Approach With a First-in-Class Acid Suppressant. |
| Supported by: Phathom Pharmaceuticals | |
| 12:15–1 p.m. | |
| DDW Theater 1 | |
| Discover a Different Mechanism of Action to Treat Adults With IBS-C: A Case Based Discussion | |
| Supported by: Ardelyx | |
| 12:50–1:35 p.m. | |
| DDW Theater 2 | |
| 1 p.m. | A Deep Dive Into MASH: Exploring the Role of Metabolic Dysfunction in Disease Pathophysiology |
| Supported by: Novo Nordisk | |
| 1:30–2:15 p.m. | |
| DDW Theater 1 | |
| 2 p.m. | The role of Nexpowder in Advancing Treatment Strategies for Upper and Lower GI Bleeding |
| Supported by: Medtronic | |
| 2:05–2:50 p.m. | |
| DDW Theater 2 | |
| The Time is Now: A Clinical Practice Model to Help Prevent Progression from Barrett’s to EAC | |
| Supported by: Castle Biosciences | |
| 2:45–3:30 p.m. | |
| DDW Theater 1 | |
| 3 p.m. | Unlocking Treatment Possibilities in PBC |
| Supported by: Ipsen Biopharmaceuticals, Inc. | |
| 3:20–4:05 p.m. | |
| DDW Theater 2 |
| 9 a.m. | Patient Focus: Help achieve endoscopic control with oral therapy for adult TNFi-IR patients with moderate to severe Crohn’s disease |
| Supported by: AbbVie | |
| 9:45–10:30 a.m. | |
| DDW Theater 1 | |
| 10 a.m. | Eosinophilic Esophagitis (EoE): Who’s in Your Waiting Room? |
| Supported by: Sanofi and Regeneron | |
| 10:20–11:05 a.m. | |
| DDW Theater 2 | |
| 11 a.m. | Advancing Excellence in Colorectal Cancer Screening: Defining Success and Challenging Assumptions |
| Supported by: Exact Sciences | |
| 11–11:45 a.m. | |
| DDW Theater 1 | |
| The robust clinical data behind the ENTYVIO (vedolizumab) Pen | |
| Supported by: Takeda Pharmaceuticals U.S.A., Inc. | |
| 11:35 a.m.–12:20 p.m. | |
| DDW Theater 2 | |
| Noon | TREMFYA®: Now Approved in Adults with Moderately to Severely Active Crohn’s Disease |
| Supported by: Johnson & Johnson | |
| 12:15–1 p.m. | |
| DDW Theater 1 | |
| Taking a Deep Dive Into Eohilia, an Oral Therapeutic Option | |
| Supported by: Takeda Pharmaceuticals U.S.A., Inc. | |
| 12:50–1:35 p.m. | |
| DDW Theater 2 | |
| 1 p.m. | The PillCam Genius SB Kit: Experience in clinical practice |
| Supported by: Medtronic | |
| 1:30–2:15 p.m. | |
| DDW Theater 1 | |
| 2 p.m. | Clinical Deep Dive: Unlocking the Treatment Potential of Rezdiffra |
| Supported by: Madrigal Pharmaceuticals | |
| 2:05–2:50 p.m. | |
| DDW Theater 2 | |
| New Data Through 2 Years from QUASAR Phase 3 Studies and Open-Label, Long-Term Extension | |
| Supported by: Johnson & Johnson | |
| 2:45–3:30 p.m. | |
| DDW Theater 1 | |
| 3 p.m. | Strategies to Overcome Recruitment and Retention Challenges in Metabolic Associated Steatotic Liver Disease |
| Supported by: Parexel | |
| 3:20–4:05 p.m. | |
| DDW Theater 2 |
Only a Few Slots Remaining!
If you are interested in booking a Product Theater for DDW, please reach out to our account managers below. If you are not currently an industry supporter, you will be required to secure booth space before you will be able to secure a Product Theater.
Companies #, A-G:
Alisa Streets
Account Manager
Industry Sales and Operations
240-482-3237 | astreets@gastro.org
Companies H-Z:
Tessa Ayala
Senior Account Manager
Industry Sales and Operations
301-657-2176 | tayala@gastro.org
Related Opportunities
Satellite Symposia
Industry supporters can host educational programs before or after DDW scientific sessions, often offering CME to participants.
In-Conjunction With Meetings
ICWs are meetings and events arranged by industry supporters, third-party planners, educational institutions or other non-profit organizations.
Book Your Space
Exceed business goals by exposing your company to key decision makers in GI. The Exhibit Hall will be open May 4-6, 2025.
